DRUG STRATEGIES (EIN 521837390) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1993

Legal Domicile

Principal Officer

MATHEA FALCO

Phone

4156386600

Tax Period

2024-07-01 to 2025-06-30

DRUG STRATEGIES, founded in 1993, is a micro nonprofit in the Public & Societal Benefit sector that reported $4K in total revenue in fiscal year 2024. Revenue fell 100% from the prior year — a significant decline worth monitoring. Expenses of $358K exceeded revenue, resulting in a 9749% operating deficit.

Mission

DRUG STRATEGIES PROMOTES MORE EFFECTIVE APPROACHES TO THE NATION'S DRUG PROBLEMS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $250

Program Service Revenue $0

Investment Income $3,389

Other Revenue $0

TOTAL REVENUE $3,639

Expense Breakdown

Grants Paid $0

Salaries & Benefits $130,763

Fundraising Expenses $28,975

Program Expenses $293,267

Other Expenses $227,640

TOTAL EXPENSES $358,403

Year-over-Year Comparison

	2024	2023	Change
Revenue	$3,639	$1,867,462	-1.0%
Expenses	$358,403	$375,191	0.0%
Net Income	$-354,764	$1,492,271	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$117,761

Total Directors

$117,761

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARIAN WRIGHT EDELMAN	DIRECTOR	1.00	Director	$0	$0	$0
LOUISE BRYSON	DIRECTOR	1.00	Director	$0	$0	$0
MORRIS PANNER	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL KANTOR	DIRECTOR	1.00	Director	$0	$0	$0
AMBASSADOR JAMES R JONES	BOARD CHAIR	1.00	Officer Director	$0	$0	$0
MARNI VLIET	DIRECTOR	1.00	Director	$0	$0	$0
DR A THOMAS MCLELLAN	DIRECTOR	1.00	Director	$0	$0	$0
MATHEA FALCO	EXECUTIVE DIR/PRESIDENT	40.00	Officer Director	$37,950	$79,811	$117,761

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$3,639	$358,403	$1,673,953	$-354,764
2024	$1,867,462	$375,191	$1,905,837	$1,492,271
2023	$73,344	$237,590	$365,764	$-164,246
2022	$182,093	$284,100	$462,658	$-102,007
2021	$118,239	$284,473	$772,173	$-166,234
2020	$192,630	$312,252	$733,871	$-119,622
2019	$156,286	$360,700	$843,669	$-204,414

DRUG STRATEGIES